Emadedin et al treated 6 moderate and severe AOAs with a single injection of autologous bone marrow derived MSCs, after a previous isolation and expansion process: clinical scores based on pain and functionality increased in the first six months and maintained a positive trend until 30 months (Emadedin et al. 2015 ).
← all excerpts
Joint sparing treatments in early ankle osteoarthritis: current procedures and future perspectives.
1
—
—